IVPost
Leading health organizations collaborate with industry on new initiative to combat growing diabetes and cardiovascular disease threat
- Details
- Written by Maggie Francis
- Category: Health News
The American Heart Association (AHA) and the American Diabetes Association (ADA) today announced the start of a new multi-year collaborative initiative supported by founding sponsors Boehringer Ingelheim, Eli Lilly and Company (Lilly), and Novo Nordisk. The initiative’s goal is to help people with type 2 diabetes reduce their risk of disability and death due to cardiovascular events such as heart attack and stroke. Additional support for the initiative is provided by national sponsor, Sanofi.
More than $28 million awarded for new atrial fibrillation research centers to improve patient outcomes
- Details
- Written by Jennifer Pratt
- Category: Health News
The American Heart Association—the world’s leading voluntary organization dedicated to building healthier lives, free of cardiovascular diseases and stroke—announced today research grants totaling more than $28 million to the scientific teams that will create a new research network focused on understanding the causes of atrial fibrillation (AFib). The new knowledge they discover will provide a basis to generate more effective ways to treat and prevent the disease.
Unprecedented innovative hospital certifications aim to improve in-hospital cardiovascular patient care
- Details
- Written by Tracie Bertaut
- Category: Medical News
A portfolio of joint programs that support a high standard of cardiovascular care for hospitals will help ensure patients have access to the most evidence-based care available. The American Heart Association, the world’s leading voluntary organization dedicated to building healthier lives, free of cardiovascular diseases and stroke, and The Joint Commission, the nation’s largest independent healthcare evaluation organization, are joining forces to provide an unprecedented focus on enhancing cardiovascular patient care through a range of innovative disease-specific hospital certifications while improving outcomes for those hospitalized with cardiovascular conditions, the number one cause of death in the United States.
Early-stage Respiratory Syncytial Virus vaccine trial begins
- Details
- Written by IVPost
- Category: Latest News
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a clinical trial of an investigational vaccine designed to protect against respiratory syncytial virus (RSV). The Phase 1 study will enroll a small group of healthy adult volunteers to examine the safety of an experimental intranasal vaccine and its ability to induce an immune response. The study is being conducted at the Cincinnati Children’s Hospital Medical Center, one of the NIAID-funded Vaccine and Treatment Evaluation Units (VTEUs).
American Heart Association and Aramark named 2018 Halo Award winners for improving diet, health of millions
- Details
- Written by Brooks Lancaster
- Category: Health News
The American Heart Association, the world’s leading voluntary health organization devoted to fighting cardiovascular disease, and Aramark, the largest U.S. food service company serving two billion meals each year, are thrilled their Healthy for Life® 20 By 20 collaboration is the 2018 Silver Halo Award winner in the health category.
Important expansion of in-hospital cardiovascular care program to drive improved patient outcomes across China
- Details
- Written by Brooks Lancaster
- Category: Health News
In-hospital, guideline-led care will now reach more hospitals, and even more people in China. The American Heart Association, the world’s leading voluntary health organization devoted to fighting cardiovascular disease, supported by funding from AstraZeneca, is seeking to expand in-hospital cardiovascular care guideline adherence through the Improving Care for Cardiovascular Disease in China project, a collaborative effort with the Chinese Society of Cardiology.
Page 1 of 45